Expression of protein mediators of type I interferon signaling in human squamous cell carcinoma of the skin

Cancer Epidemiology Biomarkers and Prevention

Volumn 9, Issue 9, 2000, Pages 993-997

  Clifford, J L ^a   Menter, D G ^a   Yang, X ^a   Walch, E ^a   Zou, C ^a   Clayman, G L ^a   Schaefer, T S ^a   El Naggar, A K ^a   Lotan, R ^a   Lippman, S M ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; PROTEIN P 48; STAT1 PROTEIN; STAT2 PROTEIN; STAT3 PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; CANCER PREVENTION; CLINICAL TRIAL; DENSITOMETRY; DRUG MECHANISM; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERFERON PRODUCTION; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE DIAGNOSIS; SIGNAL TRANSDUCTION; SKIN CANCER; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMAN; IMMUNOHISTOCHEMISTRY; INTERFERON TYPE I; SIGNAL TRANSDUCTION; SKIN; SKIN NEOPLASMS; SUPPORT, U.S. GOV'T, P.H.S.; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 0033801557     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. An overview of the interferon system: Signal transduction and mechanisms of action
2. STATs and gene regulation
3. Tyrosine-phosphorylated Stat1 and Stat2 plus a 48-kDa protein all contact DNA in forming interferon-stimulated-gene factor 3
4. STAT3 complements defects in an interferon-resistant cell line: Evidence for an essential role for STAT3 in interferon signaling and biological activities
5. Stat3: A STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6
6. STAT3 as an adapter to couple phosphatidylinositol 3-kinase to the IFNAR1 chain of the type I interferon receptor
7. Retinoids and interferons: Combination studies in human cancer
8. 13-cis-Retinoic acid and interferon α-2a: Effective combination therapy for advanced squamous cell carcinoma of the skin
9. Functional differences between Stat3α and Stat3β
10. Effects of α and β interferons on cultured human keratinocytes
11. Transcriptionally active Stat1 is required for the antiproliferative effects of both interferon α and interferon γ
12. Defective TNF-α-induced apoptosis in STAT1-null cells due to low constitutive levels of caspases
13. Proliferation of adult T cell leukemia/lymphoma cells is associated with the constitutive activation of JAK/STAT proteins
14. A novel function of Stat1 and Stat3 proteins in erythropoietin-induced erythroid differentiation of a human leukemia cell line
15. Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein
16. Activation of STAT transcription factors in oncogenic tyrosine kinase signaling
17. Stat3 as an oncogene
18. STAT3 activation accompanies keratinocyte differentiation
19. Inhibition of angiogenesis by interferons: Effects on tumor- and lymphocyte-induced vascular responses
20. Suppression of angiogenesis, tumorigenicity, and metastasis by human prostate cancer cells engineered to produce interferon-β
21. Expression of interferon-β is associated with growth arrest of murine and human epidermal cells